Abstract
Alzheimer’s disease (AD) is the most common neurodegenerative disease, characterized by notable memory loss, cognitive impairment, and personality disorders accompanied with structural abnormalities in the brain of aged population. Currently approved drugs for AD offer symptomatic relief without preventing the progression of the disease and having limited efficacy. Many experiments and clinical trials have shown that the traditional herbal medicine, which has multiple targets, could provide effective treatment of AD. Increasing evidence suggests that the plant derived polyphenols plays a key role in improving cognitive functions and preventing/delaying the onset of certain neurodegenerative diseases including AD. Although several biological effects based on experimental studies could be scientifically explained, the way to bring natural polyphenols into routine clinical application against neurodegeneration seems to be long, because of its low average daily intake, poor availability and few adverse effects. So the better knowledge about intestinal absorption, excretion, intestinal and hepatic metabolism, plasma kinetics, the nature of circulating metabolites, transport, cellular uptake, intracellular metabolism, and accumulation in tissues including brain will facilitate current scientific understanding and offer great hope for the prevention of AD.
An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-3-319-28383-8_24
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Armstrong RA. What causes Alzheimer’s disease? Folia Neuropathol. 2013;51:169–88.
Chow VW, Mattson MP, Wong PC, Gleichmann M. An overview of APP processing enzymes and products. Neuromolecular Med. 2010;12:1–12.
Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys. 2010;501:79–90.
Ebrahimi A, Schluesener H. Natural polyphenols against neurodegenerative disorders: potentials and pitfalls. Ageing Res Rev. 2012;11:329–45.
Gama Sosa MA, De Gasperi R, Elder GA. Modeling human neurodegenerative diseases in transgenic systems. Hum Genet. 2012;131:535–63.
Justin Thenmozhi A, Raja TR, Janakiraman U, Manivasagam T. Neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer’s disease in Wistar rats. Neurochem Res. 2015;40:767–76.
Kumar A, Singh A, Ekavali. A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep. 2015;67:195–203.
Maltsev AV, Bystryak S, Galzitskaya OV. The role of β-amyloid peptide in neurodegenerative diseases. Ageing Res Rev. 2011;10:440–52.
Massoud F, Gauthier S. Update on the pharmacological treatment of Alzheimer’s disease. Curr Neuropharmacol. 2010;8:69–80.
Nisbet RM, Polanco JC, Ittner LM, Gotz J. Tau aggregation and its interplay with amyloid-β. Acta Neuropathol. 2015;129:207–20.
Qian ZM, Ke Y. Huperzine A: is it an effective disease-modifying drug for Alzheimer’s disease? Front Aging Neurosci. 2014;6:216.
Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol. 2006;545:51–64.
Roskams AJ, Connor JR. Aluminum access to the brain: a role for transferrin and its receptors. Proc Natl Acad Sci USA 1990;87:9024–9027.
Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr. 2002;22:19–34.
Rowinska-Zyrek M, Salerno M, Kozlowski H. Neurodegenerative diseases - understanding their molecular bases and progress in the development of potential treatments. Coord Chem Rev. 2015;284:298–312.
Shimmyo Y, Kihara T, Akaike A, Niidome T, Sugimoto H. Epigallocatechin-3- gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation. Neuroreport 2008; 19:1329–1333.
WHO dementia report (2006). World Health Organization.
Compliance with Ethics Requirements
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Thenmozhi, A.J., Manivasagam, T., Essa, M.M. (2016). Role of Plant Polyphenols in Alzheimer’s Disease. In: Essa, M., Akbar, M., Guillemin, G. (eds) The Benefits of Natural Products for Neurodegenerative Diseases. Advances in Neurobiology, vol 12. Springer, Cham. https://doi.org/10.1007/978-3-319-28383-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-28383-8_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28381-4
Online ISBN: 978-3-319-28383-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)